bethanechol has been researched along with urapidil in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Kamai, T; Sakakibara, R; Tsujii, T; Uchiyama, T; Yamanishi, T; Yasuda, K; Yoshida, K | 1 |
1 trial(s) available for bethanechol and urapidil
Article | Year |
---|---|
Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Bethanechol; Cholinergic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Probability; Prospective Studies; Pyridinium Compounds; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Urinary Retention; Urination Disorders; Urodynamics | 2004 |
1 other study(ies) available for bethanechol and urapidil
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |